Immunohistochemistry for identification of neoplasic cells within brisk infiltrate of thin melanomas;Imuno-histoquímica para identificação de células neoplásicas no infiltrado ativo de melanomas finos

Jornal Brasileiro de Patologia e Medicina Laboratorial

Volumn 42, Issue 2, 2006, Pages 143-148

  Salvio, Ana Gabriela ^a   Alencar Marques, Mariângela Esther ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Immunohistochemistry; In situ melanomas; Melan A; Thin melanomas

Indexed keywords

EID: 33746104935     PISSN: 16762444     EISSN: 16784774     Source Type: Journal    
DOI: 10.1590/S1676-24442006000200012     Document Type: Article

References (20)

1. BERGMAN, R. et al. A comparative immunohistochemical study of MART-I expression in Spitz nevi, ordinary melanocytic nevi and malignant melanoma. J Am Acad Dermatol, v. 42, n. 3, p. 496-500, 2000.
2. BRESLOW, A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma.Ann Surg, v. 172, p. 902-8, 1970.
3. CROWSON, A. N.; MAGRO, C. M., MIHN, M. C. Malignant melanoma. In:The melanocytic proliferations: a comprehensive textbook of pigmented lesions. New York: Wiley-Liss, 2001. Cap 10., p. 281-397.
4. th ed. Lippincott Raven, 1997. Chap. 29, p. 625-84.
5. GOWN, A. M.; BACCHI, C. E. Diagnostic immunohistochemistry In: MEETING UNITED STATES - CANADIAN ACADEMY OF PATHOLOGY 2002, Chicago. Proceedings. Chicago, 2002. 63p.
6. HSU, S. M.; SOBAN, E. Color modification of diaminobenzidine (DAB) preparations by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem, v 30, p 1079, 1982.
7. JAFFER, S.; BLEIWEISS, I. Beyond hematoxylin and eosin - the role of immunohistochemistry in surgical pathology Cancer Invest, v. 22, n. 3, p. 445-65, 2004.
8. JUNGBLUTH, A. A. et al. A103: an anti Melan A monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues. Am J Surg Pathol, v. 22, n. 5, p. 595-602, 1998.
9. KAMINO, H.; TAM, S.T. Immunoperoxidase technique modified by counterstain with azure B as a diagnostic aid in evaluating heavily pigmented melanocytic neoplasms. J Cutan Pathol, v. 18, p. 436-9, 1991.
10. KELLEY, L. C.; STARKUS, L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-I. J Am Acad Dermatol, v. 46, n. 1, p. 78-84, 2002.
11. LOMUTO, M; CALABRESE, A.; GIULIANI, A. Prognostic signs in melanoma: state of the art. Eur Acad Dermatol Venereol, v. 18, p. 291-300, 2004.
12. MANGINI, J; LI, N.; BHAWAN, J. Immunohistochemical markers of melanocytic lesions. A review of their diagnostic usefulness. Am J Dermatopathol, v. 24, n. 3, p. 270-81, 2002.
13. NADJI, M Immunoperoxidase techniques. Facts and artifacts. Am J Dermatopathol, v. 8, n. 1, p. 32, 1986.
14. ORCHARD, G. E.; CALONJE, E. The effect of melanin bleaching on immunohistochemical staining in heavily pigmented melanocytic neoplasms. Am J Surg Pathol, v. 20, n. 4, p. 357-61, 1998.
15. RAMIREZ-MONTAGUT, T. et al. Melanoma antigen recognition by tumor-infiltrating T lymphocytes (TIL): effect of differential expression of Melan-A/MART-I. Clin Exp Immunol, v. 119, p. 11-8, 2000.
16. RUITER, D. J.; VAN DIJK, M. C. R. F.; FERRIER, C. M. Current diagnostic problems in melanoma pathology Semin Cutan Med Surg, v. 22, n. 1, p. 33-41, 2003.
17. SCHAUMBURG-LEVER, G. The alkaline phosphatase anti-alkaline phosphatase technique in dermatopathology. J Cutan Pathol, v. 14, p. 6, 1987.
18. SMOLLER, B. R. Practical Immunopathology of the skin. Totowa: Humana Press, 2002.
19. TAYLOR, C. R. et al. Techniques of immunohistochemistry: principals, pitfalls and standardization. In: DABBS, D. J. Diagnostic immunohistochemystry. Churchill Livingstone, 2002. Chap I. p. 3-44.
20. XU, X. et al. Immunoprofile of MITF, tyrosinase, Melan-A, and Mage-I in HMB45 - negative melanomas. Am J Surg Pathol, v. 26, n. 1, p. 82-7, 2002.